Amongst women diagnosed with early breast cancer, the probability of recurrence and subsequent death can vary substantially depending upon a number of known prognostic factors. With such heterogeneous levels of risk, the absolute effectiveness and consequently the cost-effectiveness of adjuvant chemotherapy, a treatment known to reduce the likelihood of recurrence, can also be expected to vary between patients.
| Identifer | oai:union.ndltd.org:bl.uk/oai:ethos.bl.uk:489416 |
| Date | January 2008 |
| Creators | Campbell, Helen |
| Publisher | University of Oxford |
| Source Sets | Ethos UK |
| Detected Language | English |
| Type | Electronic Thesis or Dissertation |
Page generated in 0.0017 seconds